Iranian
Biomedical Journal
Volume 26, Issue 5 (9-2022)
IBJ 2022, 26(5): 374-379 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Barzegar G, Ahmadpour E, Shahriari B, Solgi R, Motazedian M H. Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis. IBJ 2022; 26 (5) :374-379
URL: http://ibj.pasteur.ac.ir/article-1-3801-en.html
URL: http://ibj.pasteur.ac.ir/article-1-3801-en.html
Gholamreza Barzegar 
, Ehsan Ahmadpour * , Bahador Shahriari , Rahmat Solgi , Mohammad Hossein Motazedian
, Ehsan Ahmadpour * , Bahador Shahriari , Rahmat Solgi , Mohammad Hossein Motazedian
Abstract:
Background: Cryptosporidium parvum is an important coccidian parasite infecting many mammals, including human. This parasite can manifest as chronic severe diarrhea in immunocompromised individuals, especially those with AIDS. The present study reports the recombinant production of recombinant (r)P2 and rP23 antigens of C. parvum as antigens for detecting human cryptosporidiosis using indirect ELISA tests.
Methods: The coding sequences of rP2 and rP23 proteins were codon-optimized, commercially synthesized and sub-cloned in the pET28a expression vector. The expressed proteins were purified by Ni-NTA column chromatography and confirmed by Western blotting. The efficacy of rP2/rP23 proteins for serodiagnosis was evaluated by positive (n = 20) and negative (n = 20) human sera, confirmed by the Ziehl-Neelsen staining as the gold standard test.
Results: In ELISA test, the sera from C. parvum-infected patients reacted strongly to rP2/rP23. The sensitivity and specificity related to the diagnostic potential of rP2/rP23 in the ELISA assay were 100%.
Conclusion: Our results showed that combination of rP23 and rP2 antigens in ELISA significantly increases the performance of C. parvum serodiagnosis in human cryptosporidiosis.
Methods: The coding sequences of rP2 and rP23 proteins were codon-optimized, commercially synthesized and sub-cloned in the pET28a expression vector. The expressed proteins were purified by Ni-NTA column chromatography and confirmed by Western blotting. The efficacy of rP2/rP23 proteins for serodiagnosis was evaluated by positive (n = 20) and negative (n = 20) human sera, confirmed by the Ziehl-Neelsen staining as the gold standard test.
Results: In ELISA test, the sera from C. parvum-infected patients reacted strongly to rP2/rP23. The sensitivity and specificity related to the diagnostic potential of rP2/rP23 in the ELISA assay were 100%.
Conclusion: Our results showed that combination of rP23 and rP2 antigens in ELISA significantly increases the performance of C. parvum serodiagnosis in human cryptosporidiosis.
Type of Study: Full Length/Original Article |
Subject:
Molecular Microbiology
References
1. Inpankaew T, Jittapalapong S, Phasuk J, Pinyopanuwut N, Chimnoi W. Seroprevalence of Cryptosporidium parvum infection of dairy cows in three northern provinces of Thailand determined by enzyme-linked immunosorbent assay using recombinant antigen CpP23. Onderstepoort journal of veterinary research 2009; 76(2): 161-165. [DOI:10.4102/ojvr.v76i2.40]
2. Ahmadpour E, Safarpour H, Xiao L, Zarean M, Hatam-Nahavandi K, Barac A, Picot S, Rahimi MT, Rubino S, Mahami-Oskouei M, Spotin A, Nami S, Bannazadeh Baghi H. Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis. Parasite 2020; 27: 27. [DOI:10.1051/parasite/2020025]
3. Ichikawa-Seki M, Fereig RM, Masatani T, Kinami A, Takahashi Y, Kida K, Nishikawa Y. Development of CpGP15 recombinant antigen of Cryptosporidium parvum for detection of the specific antibodies in cattle. Parasitology international 2019; 69: 8-12. [DOI:10.1016/j.parint.2018.10.013]
4. Mahmoudi M, Tappeh KH, Abasi E, Aminpour A. Utility of different diagnostic tools for detection of Cryptosporidium in children with diarrhea. Archives of pediatric infectious diseases 2020; 8(1): e92033. [DOI:10.5812/pedinfect.92033]
5. Mahmoudi M, Tapeh KH, Abasi E, Sayyadi H, Aminpour A. Prevalence and genetic characterization of Cryptosporidium in pre-weaned cattle in Urmia (Northwestern Iran). The journal of infection in developing countries 2021; 15(03): 422-427. [DOI:10.3855/jidc.12122]
6. Kosek M, Alcantara C, Lima AA, Guerrant RL. Cryptosporidiosis: an update. The lancet infectious diseases 2001; 1(4): 262-269. [DOI:10.1016/S1473-3099(01)00121-9]
7. Khurana S, Chaudhary P. Laboratory diagnosis of cryptosporidiosis. Tropical parasitology 2018; 8(1): 2. [DOI:10.4103/tp.TP_34_17]
8. Elguero ME, Tomazic ML, Montes MG, Florin-Christensen M, Schnittger L, Nusblat AD. The Cryptosporidium parvum gp60 glycoprotein expressed in the ciliate Tetrahymena thermophila is immunoreactive with sera of calves infected with Cryptosporidium oocysts. Veterinary parasitology 2019; 271: 45-50. [DOI:10.1016/j.vetpar.2019.06.008]
9. Fei J, Wu H, Su J, Jin C, Li N, Guo Y, Feng Y, Xiao L. Characterization of MEDLE-1, a protein in early development of Cryptosporidium parvum. Parasites and vectors 2018; 11(1): 1-9. [DOI:10.1186/s13071-018-2889-2]
10. Benitez A, Priest JW, Ehigiator HN, McNair N, Mead JR. Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis. Vaccine 2011; 29(49): 9239-9245. [DOI:10.1016/j.vaccine.2011.09.094]
11. Priest JW, Kwon JP, Arrowood MJ, Lammie PJ. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Molecular and biochemical parasitology 2000; 106(2): 261-271. [DOI:10.1016/S0166-6851(99)00223-6]
12. Perryman LE, Jasmer DP, Riggs MW, Bohnet SG, McGuire TC, Arrowood MJ. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Molecular and biochemical parasitology 1996; 80(2): 137-147. [DOI:10.1016/0166-6851(96)02681-3]
13. Wang C, He H, Duan M. Development and evaluation of a recombinant CP23 antigen-based ELISA for serodiagnosis of Cryptosporidium parvum. Experimental parasitology 2009; 121(2): 157-162. [DOI:10.1016/j.exppara.2008.10.015]
14. Crespo Leon F, Gutierrez Diez F, Rodriguez Ferri F, Leon Vizcaino L, Cuello Gijon F, Gimeno E, Zepeda Sein C, Sánchez Vizcaíno Rodríguez J M, Cerón Madrigal J J, Cantos Gómez P, Schudel A. The translation into Spanish of the OIE Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees): problems, solutions and conclusions. Revue scientifique et technique 2005; 24(3): 1095-1104. [DOI:10.20506/rst.24.3.1639]
15. Chang AY, Chau V, Landas JA, Pang Y. Preparation of calcium competent Escherichia coli and heat-shock transformation. JEMI methods 2017; 1: 22-25.
16. Priest JW, Bern C, Xiao L, Roberts JM, Kwon JP, Lescano AG, Checkley W, Cabrera L, Moss DM, Arrowood MJ, Sterling CR, Gilman RH, Lammie PJ. Longitudinal analysis of Cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clinical and vaccine immunology 2006; 13(1): 123-131. [DOI:10.1128/CVI.13.1.123-131.2006]
17. Shahbazi P, Shayan P, Ebrahimzadeh E, Rahbari S. Specific egg yolk antibody against recombinant Cryptosporidium parvum P23 protein. Iranian journal of parasitology 2009; 4(3): 15-24.
18. Bonafonte M-T, Smith LM, Mead JR. A 23-kDa recombinant antigen of Cryptosporidium parvum induces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice. Experimental parasitology 2000; 96(1): 32-41. [DOI:10.1006/expr.2000.4545]
19. Lan DTB, Lan TT, Van Quyet P, Quang HT, Loc NH, Long PT. Cloning and expression of gene encoding P23 protein from Cryptosporidium parvum. Journal of bioscience and biotechnology 2014; 3(3): 189-193.
20. Bannai H, Nishikawa Y, Seo JY, Nakamura C, Zhang S, Kimata I, Takashima Y, Li J, Igarashi I, Xuan X. Development and evaluation of an enzyme-linked immunosorbent assay using recombinant p23 for the detection of antibodies to Cryptosporidium parvum in cattle. The journal of protozoology research 2006; 16(1-2): 9-15.
21. Kjos SA, Jenkins M, Okhuysen PC, Chappell CL. Evaluation of recombinant oocyst protein CP41 for detection of Cryptosporidium-specific antibodies. Clinical and vaccine immunology 2005; 12(2): 268-272. [DOI:10.1128/CDLI.12.2.268-272.2005]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |